-- Overall medication adherence on health outcomes
-- Health management initiatives on adherence and health outcomes
-- Co-payment on diabetes medication adherence and HbA1c levels
-- Income and out-of-pocket cost on adherence and outcomes
Formal results of these studies will be announced as they are published.
To read the study, visit http://www.joem.org/pt/re/joem/abstract.00043764-200805000- 00003.htm;jsessionid=LyGf1HCLwZmQNN4lvQGM9W5hYKrwL0pHT6RLbWWp51GmJyN0nNJ3!2 989 90308!181195629!8091!-1 (due to the length of the URL, please copy and paste into browser)
GlaxoSmithKline, one of the world's leading research-based pharmaceutical and health care companies, is committed to improving the quality of human life by enabling people to do more, feel better, and live longer.
1. Haynes RB, Yao X, Degani A et al. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005:CD000011.
2. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288:2868-2879.
3. Kaiser Family Foundation and Health Research and Educational Trust. Annual Surveys of Employer-Sponsored Health Benefits, 2000-2005.
4. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11:730-740.
5. Lexchin J, Grootendorst P. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int J Health Serv. 2004;34:101-122.
6. Goldman DP, Joyce GF, Escarce JJ et al. Pharmacy benefits and the
use of drugs by the chro
Copyright©2008 PR Newswire.
All rights reserved